174 related articles for article (PubMed ID: 21306815)
1. Protective effect of intra-peritoneal epinephrine on postoperative renal function after cisplatin-based intra-peritoneal intra-operative chemotherapy.
Pili-Floury S; Royer B; Bartholin F; Crumiere N; Combe M; Chalopin JM; Pivot X; Heyd B; Chauffert B; Samain E
Eur J Obstet Gynecol Reprod Biol; 2011 Jun; 156(2):199-203. PubMed ID: 21306815
[TBL] [Abstract][Full Text] [Related]
2. [Comparative study of different chemotherapy approaches for advanced epithelial ovarian cancer].
Chen YL; Liu YQ; Tang DH; Chu CN
Zhonghua Fu Chan Ke Za Zhi; 2008 Feb; 43(2):110-4. PubMed ID: 18683749
[TBL] [Abstract][Full Text] [Related]
3. The incidence of cisplatin nephrotoxicity post hyperthermic intraperitoneal chemotherapy (HIPEC) and cytoreductive surgery.
Hakeam HA; Breakiet M; Azzam A; Nadeem A; Amin T
Ren Fail; 2014 Nov; 36(10):1486-91. PubMed ID: 25155314
[TBL] [Abstract][Full Text] [Related]
4. Acute kidney injury in ovarian cancer patients undergoing cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy.
Sin EI; Chia CS; Tan GHC; Soo KC; Teo MC
Int J Hyperthermia; 2017 Sep; 33(6):690-695. PubMed ID: 28540777
[TBL] [Abstract][Full Text] [Related]
5. Extensive cytoreductive surgery combined with intra-operative intraperitoneal perfusion with cisplatin under hyperthermic conditions (OVHIPEC) in patients with recurrent ovarian cancer: a feasibility pilot.
van der Vange N; van Goethem AR; Zoetmulder FA; Kaag MM; van de Vaart PJ; ten Bokkel Huinink WW; Beijnen JH
Eur J Surg Oncol; 2000 Nov; 26(7):663-8. PubMed ID: 11078613
[TBL] [Abstract][Full Text] [Related]
6. Improvement in intraperitoneal intraoperative cisplatin exposure based on pharmacokinetic analysis in patients with ovarian cancer.
Royer B; Delroeux D; Guardiola E; Combe M; Hoizey G; Montange D; Kantelip JP; Chauffert B; Heyd B; Pivot X
Cancer Chemother Pharmacol; 2008 Mar; 61(3):415-21. PubMed ID: 17503047
[TBL] [Abstract][Full Text] [Related]
7. [Renal protection with amifostine during intraoperative peritoneal chemohyperthermia (IPCH) with cisplatin (CDDP) for peritoneal carcinosis. Phase 1 study].
Vaira M; Barone R; Aghemo B; Mioli PR; De Simone M
Minerva Med; 2001 Aug; 92(4):207-11. PubMed ID: 11535965
[TBL] [Abstract][Full Text] [Related]
8. Feasibility of using intraperitoneal epinephrine and cisplatin in patients with advanced peritoneal carcinomatosis.
Molucon-Chabrot C; Isambert N; Benoit L; Zanetta S; Fraisse J; Guilland JC; Royer B; Monin-Baroille P; Flesch M; Fargeot P; Coudert B; Mayer F; Fumoleau P; Chauffert B
Anticancer Drugs; 2006 Nov; 17(10):1211-7. PubMed ID: 17075321
[TBL] [Abstract][Full Text] [Related]
9. Relation between renal dysfunction requiring renal replacement therapy and promoter polymorphism of the erythropoietin gene in cardiac surgery.
Popov AF; Schulz EG; Schmitto JD; Coskun KO; Tzvetkov MV; Kazmaier S; Zimmermann J; Schöndube FA; Quintel M; Hinz J
Artif Organs; 2010 Nov; 34(11):961-8. PubMed ID: 21092038
[TBL] [Abstract][Full Text] [Related]
10. Intraoperative chemotherapy with cisplatin and epinephrine after cytoreductive surgery in patients with recurrent ovarian cancer: a phase I study.
Guardiola E; Chauffert B; Delroeux D; Royer B; Heyd B; Combe M; Benoit L; Causeret S; Demarchi M; Magnin G; Mayer F; Tixier H; Pivot X
Anticancer Drugs; 2010 Mar; 21(3):320-5. PubMed ID: 20032778
[TBL] [Abstract][Full Text] [Related]
11. Severe post-renal acute kidney injury, post-obstructive diuresis and renal recovery.
Hamdi A; Hajage D; Van Glabeke E; Belenfant X; Vincent F; Gonzalez F; Ciroldi M; Obadia E; Chelha R; Pallot JL; Das V
BJU Int; 2012 Dec; 110(11 Pt C):E1027-34. PubMed ID: 22583774
[TBL] [Abstract][Full Text] [Related]
12. Tubular dysfunction after peritonectomy and chemohyperthermic treatment with cisplatin.
La Manna G; Virzì S; Deraco M; Capelli I; Accorsi A; Dalmastri V; Comai G; Bonomi S; Grassi A; Selva S; Feliciangeli G; Scolari M; Stefoni S
In Vivo; 2006; 20(6A):703-6. PubMed ID: 17203749
[TBL] [Abstract][Full Text] [Related]
13. Acute renal failure after cardiac surgery: evaluation of the RIFLE classification.
Kuitunen A; Vento A; Suojaranta-Ylinen R; Pettilä V
Ann Thorac Surg; 2006 Feb; 81(2):542-6. PubMed ID: 16427848
[TBL] [Abstract][Full Text] [Related]
14. Randomized trial of initial therapy with melphalan versus cisplatin-based combination chemotherapy in patients with advanced ovarian carcinoma: initial and long term results--Eastern Cooperative Oncology Group Study E2878.
Wadler S; Yeap B; Vogl S; Carbone P
Cancer; 1996 Feb; 77(4):733-42. PubMed ID: 8616766
[TBL] [Abstract][Full Text] [Related]
15. Predictive risk factors of acute kidney injury after cytoreductive surgery and cisplatin-based hyperthermic intra-peritoneal chemotherapy for ovarian peritoneal carcinomatosis.
Angeles MA; Quenet F; Vieille P; Gladieff L; Ruiz J; Picard M; Migliorelli F; Chaltiel L; Martínez-Gómez C; Martinez A; Ferron G
Int J Gynecol Cancer; 2019 Feb; 29(2):382-391. PubMed ID: 30674567
[TBL] [Abstract][Full Text] [Related]
16. Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer.
Alberts DS; Liu PY; Hannigan EV; O'Toole R; Williams SD; Young JA; Franklin EW; Clarke-Pearson DL; Malviya VK; DuBeshter B
N Engl J Med; 1996 Dec; 335(26):1950-5. PubMed ID: 8960474
[TBL] [Abstract][Full Text] [Related]
17. Pre-clinical study of the epinephrine-cisplatin association for the treatment of intraperitoneal carcinomatosis.
Favoulet P; Magnin G; Guilland JC; Beltramo JL; Osmak L; Benoit L; Rat P; Douvier S; Duvillard C; Chauffert B
Eur J Surg Oncol; 2001 Feb; 27(1):59-64. PubMed ID: 11237494
[TBL] [Abstract][Full Text] [Related]
18. A phase I trial of continuous hyperthermic peritoneal perfusion with tumor necrosis factor and cisplatin in the treatment of peritoneal carcinomatosis.
Bartlett DL; Buell JF; Libutti SK; Reed E; Lee KB; Figg WD; Venzon DJ; Alexander HR
Cancer; 1998 Sep; 83(6):1251-61. PubMed ID: 9740093
[TBL] [Abstract][Full Text] [Related]
19. Does furosemide prevent renal dysfunction in high-risk cardiac surgical patients? Results of a double-blinded prospective randomised trial.
Mahesh B; Yim B; Robson D; Pillai R; Ratnatunga C; Pigott D
Eur J Cardiothorac Surg; 2008 Mar; 33(3):370-6. PubMed ID: 18243724
[TBL] [Abstract][Full Text] [Related]
20. Dose-escalated paclitaxel in 1-hour infusion with a fixed dose of cisplatin in previously untreated advanced ovarian cancer: a phase II trial of the Spanish Group for Ovarian Cancer.
Cervantes A; Mendiola C; del Campo JM; Massuti B; Casado A; Escobedo A; Moyano A; Ojeda B; Poveda A; Benito D
Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-40-S15-43. PubMed ID: 9346221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
